0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
MSD Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-15N2779
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
COVID 19 Impact on MSD Drugs Market Global Research Reports 2020 2021
BUY CHAPTERS

MSD Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15N2779
Report
September 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

MSD Drugs - Market Size

The global market for MSD Drugs was estimated to be worth US$ 82410 million in 2023 and is forecast to a readjusted size of US$ 110750 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

MSD Drugs - Market

MSD Drugs - Market

Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon 
The Musculoskeletal Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the musculoskeletal system, including arthritis, osteoporosis, and musculoskeletal pain. This market encompasses various therapeutic areas such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, disease-modifying antirheumatic drugs (DMARDs), and bone health medications. The Musculoskeletal Disorders Drugs market has been witnessing steady growth due to factors such as the aging population, increasing prevalence of musculoskeletal disorders, and advancements in drug development. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of musculoskeletal disorders and improving access to healthcare.

Report Scope

This report aims to provide a comprehensive presentation of the global market for MSD Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of MSD Drugs by region & country, by Type, and by Application.
The MSD Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MSD Drugs.
Market Segmentation

Scope of MSD Drugs - Market Report

Report Metric Details
Report Name MSD Drugs - Market
Forecasted market size in 2030 US$ 110750 million
CAGR 4.2%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Amgen, Johnson & Johnson, Roche, Pfizer Inc, Eli Lilly, Merck, Novartis, UCB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of MSD Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of MSD Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of MSD Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the MSD Drugs - Market size in 2030?

Ans: The MSD Drugs - Market size in 2030 will be US$ 110750 million.

Who are the main players in the MSD Drugs - Market report?

Ans: The main players in the MSD Drugs - Market are AbbVie, Amgen, Johnson & Johnson, Roche, Pfizer Inc, Eli Lilly, Merck, Novartis, UCB

What are the Application segmentation covered in the MSD Drugs - Market report?

Ans: The Applications covered in the MSD Drugs - Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the MSD Drugs - Market report?

Ans: The Types covered in the MSD Drugs - Market report are OTC, Rx Drugs

Recommended Reports

Pain & Inflammation

Joint & Musculoskeletal

Autoimmune & Rare Diseases

1 Market Overview
1.1 MSD Drugs Product Introduction
1.2 Global MSD Drugs Market Size Forecast
1.2.1 Global MSD Drugs Sales Value (2019-2030)
1.2.2 Global MSD Drugs Sales Volume (2019-2030)
1.2.3 Global MSD Drugs Sales Price (2019-2030)
1.3 MSD Drugs Market Trends & Drivers
1.3.1 MSD Drugs Industry Trends
1.3.2 MSD Drugs Market Drivers & Opportunity
1.3.3 MSD Drugs Market Challenges
1.3.4 MSD Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global MSD Drugs Players Revenue Ranking (2023)
2.2 Global MSD Drugs Revenue by Company (2019-2024)
2.3 Global MSD Drugs Players Sales Volume Ranking (2023)
2.4 Global MSD Drugs Sales Volume by Company Players (2019-2024)
2.5 Global MSD Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers MSD Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers MSD Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of MSD Drugs
2.9 MSD Drugs Market Competitive Analysis
2.9.1 MSD Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by MSD Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MSD Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 OTC
3.1.2 Rx Drugs
3.2 Global MSD Drugs Sales Value by Type
3.2.1 Global MSD Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global MSD Drugs Sales Value, by Type (2019-2030)
3.2.3 Global MSD Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global MSD Drugs Sales Volume by Type
3.3.1 Global MSD Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global MSD Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global MSD Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global MSD Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.2 Global MSD Drugs Sales Value by Application
4.2.1 Global MSD Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global MSD Drugs Sales Value, by Application (2019-2030)
4.2.3 Global MSD Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global MSD Drugs Sales Volume by Application
4.3.1 Global MSD Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global MSD Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global MSD Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global MSD Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global MSD Drugs Sales Value by Region
5.1.1 Global MSD Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global MSD Drugs Sales Value by Region (2019-2024)
5.1.3 Global MSD Drugs Sales Value by Region (2025-2030)
5.1.4 Global MSD Drugs Sales Value by Region (%), (2019-2030)
5.2 Global MSD Drugs Sales Volume by Region
5.2.1 Global MSD Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global MSD Drugs Sales Volume by Region (2019-2024)
5.2.3 Global MSD Drugs Sales Volume by Region (2025-2030)
5.2.4 Global MSD Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global MSD Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America MSD Drugs Sales Value, 2019-2030
5.4.2 North America MSD Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe MSD Drugs Sales Value, 2019-2030
5.5.2 Europe MSD Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific MSD Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific MSD Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America MSD Drugs Sales Value, 2019-2030
5.7.2 South America MSD Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa MSD Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa MSD Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions MSD Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions MSD Drugs Sales Value
6.2.1 Key Countries/Regions MSD Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions MSD Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States MSD Drugs Sales Value, 2019-2030
6.3.2 United States MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States MSD Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe MSD Drugs Sales Value, 2019-2030
6.4.2 Europe MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe MSD Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China MSD Drugs Sales Value, 2019-2030
6.5.2 China MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China MSD Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan MSD Drugs Sales Value, 2019-2030
6.6.2 Japan MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan MSD Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea MSD Drugs Sales Value, 2019-2030
6.7.2 South Korea MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea MSD Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia MSD Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia MSD Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India MSD Drugs Sales Value, 2019-2030
6.9.2 India MSD Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India MSD Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie MSD Drugs Product Offerings
7.1.5 AbbVie Recent Development
7.2 Amgen
7.2.1 Amgen Company Information
7.2.2 Amgen Introduction and Business Overview
7.2.3 Amgen MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amgen MSD Drugs Product Offerings
7.2.5 Amgen Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Introduction and Business Overview
7.3.3 Johnson & Johnson MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson MSD Drugs Product Offerings
7.3.5 Johnson & Johnson Recent Development
7.4 Roche
7.4.1 Roche Company Information
7.4.2 Roche Introduction and Business Overview
7.4.3 Roche MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Roche MSD Drugs Product Offerings
7.4.5 Roche Recent Development
7.5 Pfizer Inc
7.5.1 Pfizer Inc Company Information
7.5.2 Pfizer Inc Introduction and Business Overview
7.5.3 Pfizer Inc MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Inc MSD Drugs Product Offerings
7.5.5 Pfizer Inc Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Company Information
7.6.2 Eli Lilly Introduction and Business Overview
7.6.3 Eli Lilly MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Eli Lilly MSD Drugs Product Offerings
7.6.5 Eli Lilly Recent Development
7.7 Merck
7.7.1 Merck Company Information
7.7.2 Merck Introduction and Business Overview
7.7.3 Merck MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck MSD Drugs Product Offerings
7.7.5 Merck Recent Development
7.8 Novartis
7.8.1 Novartis Company Information
7.8.2 Novartis Introduction and Business Overview
7.8.3 Novartis MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novartis MSD Drugs Product Offerings
7.8.5 Novartis Recent Development
7.9 UCB
7.9.1 UCB Company Information
7.9.2 UCB Introduction and Business Overview
7.9.3 UCB MSD Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 UCB MSD Drugs Product Offerings
7.9.5 UCB Recent Development
8 Industry Chain Analysis
8.1 MSD Drugs Industrial Chain
8.2 MSD Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 MSD Drugs Sales Model
8.5.2 Sales Channel
8.5.3 MSD Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. MSD Drugs Market Trends
    Table 2. MSD Drugs Market Drivers & Opportunity
    Table 3. MSD Drugs Market Challenges
    Table 4. MSD Drugs Market Restraints
    Table 5. Global MSD Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global MSD Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global MSD Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global MSD Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market MSD Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers MSD Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers MSD Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of MSD Drugs
    Table 13. Global MSD Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MSD Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global MSD Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global MSD Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global MSD Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global MSD Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global MSD Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global MSD Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global MSD Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global MSD Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global MSD Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global MSD Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global MSD Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global MSD Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global MSD Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global MSD Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global MSD Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global MSD Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global MSD Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global MSD Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global MSD Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global MSD Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global MSD Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global MSD Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global MSD Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global MSD Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global MSD Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global MSD Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global MSD Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global MSD Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global MSD Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global MSD Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global MSD Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global MSD Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global MSD Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global MSD Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global MSD Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global MSD Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions MSD Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions MSD Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions MSD Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions MSD Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions MSD Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. AbbVie Company Information
    Table 58. AbbVie Introduction and Business Overview
    Table 59. AbbVie MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. AbbVie MSD Drugs Product Offerings
    Table 61. AbbVie Recent Development
    Table 62. Amgen Company Information
    Table 63. Amgen Introduction and Business Overview
    Table 64. Amgen MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Amgen MSD Drugs Product Offerings
    Table 66. Amgen Recent Development
    Table 67. Johnson & Johnson Company Information
    Table 68. Johnson & Johnson Introduction and Business Overview
    Table 69. Johnson & Johnson MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Johnson & Johnson MSD Drugs Product Offerings
    Table 71. Johnson & Johnson Recent Development
    Table 72. Roche Company Information
    Table 73. Roche Introduction and Business Overview
    Table 74. Roche MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Roche MSD Drugs Product Offerings
    Table 76. Roche Recent Development
    Table 77. Pfizer Inc Company Information
    Table 78. Pfizer Inc Introduction and Business Overview
    Table 79. Pfizer Inc MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Pfizer Inc MSD Drugs Product Offerings
    Table 81. Pfizer Inc Recent Development
    Table 82. Eli Lilly Company Information
    Table 83. Eli Lilly Introduction and Business Overview
    Table 84. Eli Lilly MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Eli Lilly MSD Drugs Product Offerings
    Table 86. Eli Lilly Recent Development
    Table 87. Merck Company Information
    Table 88. Merck Introduction and Business Overview
    Table 89. Merck MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Merck MSD Drugs Product Offerings
    Table 91. Merck Recent Development
    Table 92. Novartis Company Information
    Table 93. Novartis Introduction and Business Overview
    Table 94. Novartis MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Novartis MSD Drugs Product Offerings
    Table 96. Novartis Recent Development
    Table 97. UCB Company Information
    Table 98. UCB Introduction and Business Overview
    Table 99. UCB MSD Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. UCB MSD Drugs Product Offerings
    Table 101. UCB Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. MSD Drugs Downstream Customers
    Table 105. MSD Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. MSD Drugs Product Picture
    Figure 2. Global MSD Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global MSD Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global MSD Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. MSD Drugs Report Years Considered
    Figure 7. Global MSD Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global MSD Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by MSD Drugs Revenue in 2023
    Figure 10. MSD Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. OTC Picture
    Figure 12. Rx Drugs Picture
    Figure 13. Global MSD Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global MSD Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global MSD Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global MSD Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global MSD Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Retail Pharmacy
    Figure 20. Global MSD Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global MSD Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global MSD Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global MSD Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global MSD Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America MSD Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe MSD Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific MSD Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America MSD Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa MSD Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa MSD Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions MSD Drugs Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions MSD Drugs Sales Volume (%), (2019-2030)
    Figure 37. United States MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. China MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. China MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. India MSD Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India MSD Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. India MSD Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. MSD Drugs Industrial Chain
    Figure 59. MSD Drugs Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart